• #693951
  • 848
  • Ansell #6034512

Exam Glove Micro-Touch® NitraFree™ Medium NonSterile Nitrile Standard Cuff Length Textured Fingertips Pink Chemo Tested

GLOVE, EXAM MICROTCH NITRL LF PF PNK MED (100/BX)

Features
  • This glove is tested for use with the following 8 chemotherapy drugs: Vincristine Sulfate, Cyclophosphamide (Cytoxan), Doxorubicin Hydrochloride, 5-Fluorouracil, Methotrexate, Etoposide (Toposar), Paclitaxel (Taxol) and Thiotepa
  • Does not contain any sulfur-based accelerators such as thiurams, carbamates, thiazoles, guanidine or thioureas
  • In 2010-2011, Ansell will donate $2 per case sold of the Micro-Touch* NitraFree* to Susan G. Komen for the Cure*, with a guaranteed minimum donation of $25,000
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #693951
Manufacturer #6034512
BrandMicro-Touch® NitraFree™
ManufacturerAnsell
Country of OriginMalaysia
ApplicationExam Glove
Chemo RatedChemo Tested
ColorPink
Cuff StyleBeaded Cuff
Fingertip Thickness0.16 mm (6.3 mil)
Glove ExteriorTextured Fingertips
Glove InteriorWithout Coating
Glove LengthStandard Cuff Length
Hand CompatibilityAmbidextrous
Length in Inches9.44 Inch
MaterialNitrile
Powder ContentPowder Free
SizeMedium
SterilityNonSterile
UNSPSC Code42132203
UsageSingle Patient Use
Latex Free IndicatorNot Made with Natural Rubber Latex
Features
  • This glove is tested for use with the following 8 chemotherapy drugs: Vincristine Sulfate, Cyclophosphamide (Cytoxan), Doxorubicin Hydrochloride, 5-Fluorouracil, Methotrexate, Etoposide (Toposar), Paclitaxel (Taxol) and Thiotepa
  • Does not contain any sulfur-based accelerators such as thiurams, carbamates, thiazoles, guanidine or thioureas
  • In 2010-2011, Ansell will donate $2 per case sold of the Micro-Touch* NitraFree* to Susan G. Komen for the Cure*, with a guaranteed minimum donation of $25,000
  • The textured fingertips of the glove provide extra protection for wet or dry grip and against slippage
  • Meets ASTM requirements for testing parameters for specific hazardous drugs-http://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare
More Information